MGEN Builds Culture Through Everyday Practice

MGEN builds its workplace culture through everyday practices that bring its values into employee collaboration, inclusion, safety, wellness, and shared experiences.

Nestlé Supports Department Of Agriculture’s Push For Stronger Philippine Coffee Industry

Nestlé welcomed the Department of Agriculture’s creation of the Coffee Industry Development Office as a step toward strengthening the Philippine coffee industry.

From Digital Community To Lasting Movement: KasKasan Buddies Looks Ahead

With scams constantly changing, KasKasan Buddies sees its nationwide membership as an early-warning network where experiences can help others recognize emerging fraud tactics.

Alex Eala For Panasonic: Bringing Excellence Closer To Home

Alex Eala brings global tennis excellence closer to home as she begins a new chapter with Panasonic Philippines.

EU Meets 70% Vaccination Target By July

The European Union reached its target of vaccinating 70 percent of its adult population with at least one jab by July, the bloc’s top official confirmed Tuesday.

EU Meets 70% Vaccination Target By July

85
85

How do you feel about this story?

Express Your Reaction
Like
Love
Haha
Wow
Sad
Angry

The European Union reached its target of vaccinating 70 percent of its adult population with at least one jab by July, the bloc’s top official confirmed on Tuesday.

“The EU has kept its word and delivered,” Ursula von der Leyen, the president of the European Commission, announced in a video statement.

At least 57 percent of adults have already been fully vaccinated, she added.

Von der Leyen also warned of the dangers of the highly contagious Delta variant and urged everyone who has not been inoculated yet to get their jabs.

The European Commission set in March the objective to vaccinate 70 percent of the adult population — a minimum to reach herd immunity — by July.

The jabs were provided in the framework of bloc’s advanced purchase agreements with six vaccine producers — Pfizer/BioNTech, Moderna, AstraZeneca, CureVac, Johnson & Johnson, and Sanofi/GlaxoSmithKline — to buy about 2.6 billion vaccine doses.

In addition, the European Commission agreed with Pfizer/BioNTech to purchase another 1.8 billion doses for 2022 and 2023. (PNA)